Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study

بواسطة Beatriz Grinsztejn, Michael D. Hughes, Justin Ritz, Robert Salata, Peter Mugyenyi, Evelyn Hogg, Linda Wieclaw, Robert Gross, Catherine Godfrey, Sandra W. Cardoso, Aggrey Bukuru, Mumbi Makanga, Sharlaa Faesen, Vidya Mave, Beatrice Wangari Ndege, Sandy Nerette Fontain, Wadzanai Samaneka, Rode Secours, Marije van Schalkwyk, Rosie Mngqibisa, Lerato Mohapi, Javier Valencia, Patcharaphan Sugandhavesa, Esmelda Montalban, Anchalee Avihingsanon, Breno R. Santos, Nagalingeswaran Kumarasamy, Cecilia Kanyama, Robert T. Schooley, John W. Mellors, Carole L. Wallis, Ann C. Collier, B. Grinsztejn, P. N. Mugyenyi, A. Collier, R. Salata, C. Godfrey, E. Hogg, M. Hughes, J. Ritz, L. Wieclaw, T. Sise, J. W. Mellors, C. Wallis, C. V. Fletcher, M. Gandhi, R. Gross, R. T. Schooley, R. Walensky, M. van Schalkwyk, S. Faesen, R. Mngqibisa, J. Valencia, E. Montalban, N. Kumarasamy, C. Kanyama, S. W. Cardoso, B. R. Santos, B. Mansfield, H. Mugerwa, B. W. Ndege, R. Secours, W. Samaneka, D. Kadam, V. Mave, M. Makanga, S. N. Fontain, P. Sugandhavesa, A. Avihingsanon, L. Nakibuuka, H. Nassolo, P. Anthony, V. Kulkarni, M. Nsubuga, J. van Wyk, J. Rooney, Y. van Delft, R. Leavitt, R. Luk, A. Benns, L. Hovind, A. Shahkolahi
منشور في 2019